Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The current authors have previously identified
BR22
, a thyroid transcription factor (TTF)-1 associated protein 26 (
TAP26
), which interacts with TTF-1 to enhance human surfactant protein (SP)-B promoter activity in transfected 293 cells. However, the expression of
TAP26
in the lung cells and its biological relevance to the SP-B production under physiological conditions were not examined. In this study, endogenous co-immunoprecipitation and in situ immunohistochemical staining techniques were employed to explore the presence of
TAP26
and TTF-1 complex in the lung epithelial cells. The correlation of
TAP26
, TTF-1 and SP-B expression was inspected in H441 cells in the presence of dexamethasone, a known positive effector of the SP-B promoter. Monoclonal antibody (mAb) against
TAP26
can co-immunoprecipitate both
TAP26
and TTF-1 from H441 cells. Using this antibody in in situ staining of human lung sections, the data show that
TAP26
is present in the lung alveolar epithelial cells. Reverse
transcriptase
-polymerase chain reaction and Western blot analyses of type-II cells as well as dexamethasone-treated H441 cells suggest that
TAP26
expression is modulated coordinately with SP-B and TTF-1 in these cells. In summary, the current study demonstrates that thyroid transcription factor-1 associated protein 26 is an associated protein of thyroid transcription factor-1 in the lung alveolar epithelial cells where surfactant protein gene expressions take place in vivo.
...
PMID:BR22, a 26 kDa thyroid transcription factor-1 associated protein (TAP26), is expressed in human lung cells. 1288 43